Human Performance
Technologies to enhance, restore, and extend human capabilities
Human Performance covers technologies that enhance, restore and extend strength, cognition and metabolic health, and address the biology of aging. Averin Capital, an early-stage venture capital firm in New York, invests in companies helping people keep these capabilities throughout life and recover them after illness or injury.
- Focus 01
- Physical performance
- Focus 02
- Cognitive health
- Focus 03
- Metabolic health
- Focus 04
- Healthy aging
What we invest in
Strength, cognition, and metabolic health shape how people function throughout life. We invest in technologies that help preserve these capabilities, restore them after illness or injury, and address the biological processes behind aging.
How we work with founders
Averin’s partners have built and run companies. We help founders with operating choices, anticipate challenges, and connect them with the people who matter across technology, science and healthcare.
Our partnerships rest on candid communication, mutual trust, forward planning and execution informed by data and specialist networks.
Questions
Does Averin Capital invest in Human Performance?
Yes. Human Performance is one of Averin’s five investment areas, alongside Foundational Science, Physical Intelligence, Care Delivery and Healthcare Infrastructure.
What stage does Averin invest in?
Averin invests from pre-seed through later stages and also creates companies. Typical initial investments range from $500,000 to $10 million, and Averin sometimes leads rounds.
Where does Averin invest?
Averin is based in New York and invests in companies in the United States, Europe and Asia.
Does a company need to use AI to fit?
No. AI is a capability that runs across Averin’s areas, not a requirement for every investment.
Other areas
-
-
-
-
Building in Human Performance?
Tell us what you’re working on Read Perspectives